Clinical trial · Observational
National Registry and Blood Bank of Patients With Liver Cancer
A National Registry of Patients With Hepatocellular Carcinoma
NCT00482365CI-TRIAL-00011793completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Gathering health information about patients with liver cancer over time may help doctors learn more about the disease and may help the study of cancer in the future. PURPOSE: This clinical trial is developing a national registry and blood bank of patients with liver cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Cancer | Malignant Liver Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| biologic sample preservation procedure | Other | — | UNRESOLVED |
| medical chart review | Other | — | UNRESOLVED |
| Patient interview | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Etiologic factors associated with hepatocellular carcinoma in different ethnic groups across the US
- timeFrame
- every 6 months up to 5 years
- description
- A descriptive analysis will be done to describe the number of patients with HCC, their underlying etiology, correlation between etiology and demographic features and the outcome of various forms of therapy. Survival analysis will be done, comparing various forms of therapy while adjusting for stage of disease.
Secondary outcomes (1)
- measure
- Serum repository for registry patients
- timeFrame
- At study entry
- description
- blood samples will be drawn at the time of standard of care and stored.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of hepatocellular carcinoma at a participating institution Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.